MeMed
-
MeMed raises $93 M to accelerate commercialisation of host immune-response product portfolio
MeMed BV test recently cleared for use by US FDA to aid in distinguishing between bacterial and viral infection on…
Read More »
MeMed BV test recently cleared for use by US FDA to aid in distinguishing between bacterial and viral infection on…
Read More »